Product Specifications

Key Features & Clinical Applications

• Extended Detection Window: Provides reliable verification of alcohol abstinence or consumption over the preceding 3 to 4 days, vastly outperforming standard saliva or breath tests.

• Precise 300 ng/mL Cutoff: Calibrated to a tight 300 ng/mL threshold to maximize screening sensitivity while helping to filter out incidental trace exposures (such as standard alcohol-based hand sanitizers or mouthwashes).

• High-Contrast Membrane: Engineered with an easy-to-read, clean-background visual display where two crisp color lines indicate a negative result and a single control line establishes a presumptive positive.

• Streamlined T-Dip® Design: Built with a protective structural cap and specialized narrow immunoassay strips to enable direct, hygienic dipping into standard urine collection beakers without sample cross-contamination.

• Institutional Utility: Highly utilized across drug courts, sober living environments, military screening protocols, and psychiatric monitoring programs.

⚠️ Regulatory Status Warning: Forensic Use Only. This monitoring device is classified exclusively as an FUO product within the United States. It is not cleared by the FDA for clinical diagnostic utility or therapeutic treatment tracking in traditional medical facilities.

⚠️ Presumptive Status Note: This assay delivers a preliminary, qualitative screening result. For definitive, legally defensible quantification, all presumptive positive results must be verified via confirmatory laboratory molecular methods such as LC-MS/MS or GC-MS.

⚠️ Handling Protocol: Ensure the sealed foil pouch reaches ambient room temperature before opening. Do not immerse the dip card past the clear horizontal “MAX” line indicator printed along the bottom exposure strips.